Template:Subacute sclerosing panencephalitis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 40: Line 40:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Subacute sclerosing panencephalitis epidemiology and demographics|Epidemiology and Demographics]]
[[Subacute sclerosing panencephalitis causes|Causes]]
|-  
|-  
!
!
Line 46: Line 46:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Subacute sclerosing panencephalitis risk factors|Risk Factors]]
[[Subacute sclerosing panencephalitis differential diagnosis|Differentiating Subacute sclerosing panencephalitis from other Diseases]]
|-  
|-  
!
!
Line 52: Line 52:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Subacute sclerosing panencephalitis causes|Causes]]
[[Subacute sclerosing panencephalitis epidemiology and demographics|Epidemiology and Demographics]]
|-  
|-  
!
!
Line 58: Line 58:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Subacute sclerosing panencephalitis differential diagnosis|Differentiating Subacute sclerosing panencephalitis from other Diseases]]
[[Subacute sclerosing panencephalitis risk factors|Risk Factors]]
|-  
|-  
!
!
Line 132: Line 132:
[[Subacute sclerosing panencephalitis primary prevention|Primary Prevention]]
[[Subacute sclerosing panencephalitis primary prevention|Primary Prevention]]
|-  
|-  
!  
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Subacute sclerosing panencephalitis secondary prevention|Secondary Prevention]]
[[Subacute sclerosing panencephalitis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-  
|-  
!  
!  
Line 142: Line 142:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Subacute sclerosing panencephalitis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
[[Subacute sclerosing panencephalitis future or investigational therapies|Future or Investigational Therapies]]
|-  
!
 
|- bgcolor="CadetBlue"
!
Case Studies
|-  
|-  
!  
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Subacute sclerosing panencephalitis future or investigational therapies|Future or Investigational Therapies]]
[[Subacute sclerosing panencephalitis case study one|Case #1]]
|-  
|-  
!  
!


|- bgcolor="PaleGoldenrod "
|- bgcolor="PaleGoldenrod "

Latest revision as of 15:19, 14 December 2012